Stockscreener 앱 받기
28.95
4.10%
1.13
전일 마감가:
$27.82
열려 있는:
$27.97
하루 거래량:
1.64M
Relative Volume:
0.34
시가총액:
$14.73B
수익:
$17.28B
순이익/손실:
$108.00M
주가수익비율:
144.75
EPS:
0.2
순현금흐름:
$391.00M
1주 성능:
+2.91%
1개월 성능:
-16.90%
6개월 성능:
-20.98%
1년 성능:
-26.72%
1일 변동 폭
$27.92
$28.97
1주일 범위
$26.78
$28.96
52주 변동 폭
$26.25
$41.18
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(847) 948-2000
주소
ONE BAXTER PKWY, DEERFIELD, IL
BAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
28.93 | 14.73B | 17.28B | 108.00M | 391.00M | 0.20 |
|
ISRG
Intuitive Surgical Inc
|
487.05 | 173.82B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
201.13 | 57.28B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.35 | 45.42B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
214.01 | 31.24B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.37 | 15.78B | 3.90B | 392.30M | 288.10M | 1.95 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
The Latest Breaking News on Here's What to Expect From Baxter International’s Next Earnings Report - inkl
Here's What to Expect From Baxter International’s Next Earnings Report - TradingView
Dodge & Cox Buys 5,779,100 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Here's What To Expect From Baxter International’s Next Earnings Report - Barchart.com
Baxter International Inc. (NYSE:BAX) Shares Acquired by Jaffetilchin Investment Partners LLC - MarketBeat
Baxter to Host First-Quarter 2025 Financial Results Conference C - GuruFocus
Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors - The Joplin Globe
Latest Trends in Adhesion Barrier Market: 2024 to 2031 | Baxter - openPR.com
LSV Asset Management Has $159.96 Million Stake in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) Reaches New 1-Year LowShould You Sell? - MarketBeat
BAX Stock Declines Despite Latest Product Launch Boosting Patient Care - TradingView
Baxter International (BAX) Q3 2024 Earnings Call Transcript - Fortune
Russell Investments Group Ltd. Grows Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) Hits New 1-Year LowHere's Why - MarketBeat
Baxter International Enters Oversold Territory (BAX) - Nasdaq
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery - PharmiWeb.com
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat - GuruFocus
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com
Cullen Capital Management LLC Decreases Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Breakthrough: Baxter's Enhanced Hemopatch Eliminates Surgery Prep Time with Room-Temperature Storage - Stock Titan
Geode Capital Management LLC Buys 290,279 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Wound Care Market to Witness Remarkable Growth with 3M, Baxter, - openPR.com
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Baxter International Inc.(BAX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Artificial Kidney Market to See Revolutionary Growth | Baxter - openPR.com
Baxter International Inc (BAX) Shares Down 3.27% on Apr 7 - GuruFocus
Citigroup Adjusts Baxter International Price Target to $35 From $37, Maintains Neutral Rating - MarketScreener
Baxter stock touches 52-week low at $28.22 amid market challenges - Investing.com Australia
Baxter stock touches 52-week low at $28.22 amid market challenges By Investing.com - Investing.com South Africa
Intravenous Solutions Market Is Booming Worldwide | Baxter - openPR.com
Allstate Corp Makes New $450,000 Investment in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) CEO Change as Stock Dips 2% Last Quarter - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Short Interest Update - MarketBeat
Healthcare: Policy Uncertainty Is Countered by Interest in Defensive Stocks - Morningstar
US hospitals strained by IV fluid supply limits after Helene hit production site - AOL.com
Evercore ISI Adjusts Baxter International Price Target to $45 From $44, Maintains Outperform Rating - MarketScreener
Baxter International Inc. (NYSE:BAX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Baxter CEO pay surged before his departure — along with the median employee’s wage - Medical Design & Outsourcing
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.87%
0.53%
자본화:
|
볼륨(24시간):